Cinemark Holdings Inc Dossier - Source-backed chat

Cinemark Holdings Inc

CNKNYSE

SectorCommunication Services

IndustryEntertainment

Beta (adjusted)0.99

Intrinsic Value $77.07median of 5 methods · middle span $25-$156based on filings through 31 Mar 2026

Market Price $36.18Price as of 1 Oct 2026

Significantly undervaluedIntrinsic value is 113% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+113%)

Data confidence Sign in to view data confidence

Market Cap $4.2B

Enterprise Value $6.1B

Shares Outstanding 129.6M diluted

Next Earnings Date4 Nov 2026

Last ex-dividend26 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Cinemark Holdings, Inc. (NYSE: CNK) is demonstrating a robust post-pandemic recovery, driven by a highly constructive 2026 film slate, strong operational execution, and industry-leading margins. Unlike its highly leveraged peers, Cinemark maintains a best-in-class balance sheet with a net leverage ratio of 2.6x, well within its target range. The company's strategic focus on premium formats (such as its proprietary Cinemark XD brand) and its highly successful Movie Club subscription program (boasting 1.45 million members) allow it to maximize per-patron monetization and drive repeat attendance. First-quarter 2026 results validated this momentum, with revenue growing 19% year-over-year to $643.1 million and Adjusted EBITDA surging 143% to $88.5 million. With valuation multiples trading at attractive levels relative to historical averages and peers, Cinemark represents a compelling investment opportunity in the recovering theatrical exhibition sector.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets11 analysts · as of 18 Aug 2026

Low · most bearish analyst$33.00

Mean target$39.27

High · most bullish analyst$43.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$33.00

A weaker-than-expected film slate or unexpected studio delays disrupt theatrical momentum, leading to a decline in attendance. Intense competition from streaming platforms and alternative out-of-home entertainment options pressures ticket pricing and limits concession spend growth. Persistent wage inflation in Latin America and elevated utility costs compress operating margins, while high net leverage relative to historical pre-pandemic levels limits financial flexibility.

Base CaseCentral scenario

$39.27

Matches the consensus mean

The theatrical exhibition industry continues its steady recovery, supported by a normalized release cadence and stronger film volume. Cinemark maintains its market share and continues to grow its Movie Club membership base. Domestic food and beverage per-capita spend remains stable or grows slightly, offsetting moderate wage inflation and utility cost pressures. Capital expenditures of approximately $250 million in 2026 successfully convert more screens to laser projection and upgrade premium amenities, supporting a steady valuation re-rating.

Bull CaseUpside scenario

$43.00

The 2026 and 2027 film slates outperform expectations with multiple breakout blockbusters, driving domestic box office revenues back toward pre-pandemic levels. Cinemark successfully captures incremental market share through its premium large-format (PLF) screens and Luxury Lounger recliners. Concession per-capita spending continues its upward trajectory, supported by larger sizes and strategic pricing. Operating leverage drives Adjusted EBITDA margins above 20%, allowing the company to accelerate debt retirement and increase capital returns to shareholders.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Best-in-class balance sheet among major theatrical exhibitors, with net leverage at 2.6x and no near-term debt maturities until 2028.
Proprietary premium large-format brand (Cinemark XD) avoids third-party licensing fees (like IMAX), retaining higher profit margins per ticket.
Highly successful Movie Club loyalty program with 1.45 million members, driving predictable repeat attendance and valuable customer data.
Strong operational efficiency and cost discipline, resulting in superior Adjusted EBITDA margins compared to industry peers.

Key Investment Risks

High dependence on Hollywood studio production volume, quality, and theatrical release schedules, which are outside of management's control.
Macroeconomic pressures on consumer discretionary spending, which could impact theater attendance and high-margin concession sales.
Margin compression from wage inflation, particularly in Latin American operations, and elevated utility costs globally.

Thesis Invalidation Triggers

A significant reduction in the planned theatrical release slate by major Hollywood studios in favor of direct-to-consumer streaming.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.